Fumiyuki Shirai

7PUBLICATIONS
37CO-AUTHORS
Cell and nuclear divisionEpigenetics (incl. genome methylation and epigenomics)Genetically modified animalsCheminformatics and quantitative structure-activity relationshipsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 27, 2026
HTD1265 Disrupts GimC-Dependent Cellular Processes in Saccharomyces cerevisiae.

Kaori Itto-Nakama, Naoya Hosoyamada, Shinsuke Ohnuki

|Aug 31, 2025
A Novel PROTAC G9a/GLP Degrader that Inhibits, Similar to G9a siRNA, the Migration of MCF-7 Breast-Cancer Cells without Affecting Proliferation.

Anirban Mukherjee, Yasunobu Yamashita, Ryo Maeda

|Nov 29, 2024
Cell-type specific, inducible and acute degradation of targeted protein in mice by two degron systems.

Motoi Yamashita, Chihiro Ogawa, Baihao Zhang

|Mar 08, 2023
Discovery of Novel Substrate-Competitive Lysine Methyltransferase G9a Inhibitors as Anticancer Agents.

Yosuke Nishigaya, Shohei Takase, Tatsunobu Sumiya

|Jan 12, 2023
A specific G9a inhibitor unveils BGLT3 lncRNA as a universal mediator of chemically induced fetal globin gene expression.

Shohei Takase, Takashi Hiroyama, Fumiyuki Shirai

|Mar 24, 2020
Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer.

Fumiyuki Shirai, Anna Mizutani, Yoko Yashiroda

Pageof 2

Frequent Collaborators

3 joint publications

Hideaki Niwa

2 joint publications

Hitomi Yuki

2 joint publications

Teruki Honma

2 joint publications

Takashi Umehara